Related Experiment Videos
Inhomogeneous deposition of radiopharmaceuticals at the cellular level: experimental evidence and dosimetric
G M Makrigiorgos1, S Ito, J Baranowska-Kortylewicz
1Department of Radiology, Harvard Medical School, Shields Warren Radiation Laboratory, Boston, Massachusetts 02115.
Abstract:
We have undertaken an experimental examination of the conventional internal dosimetry assumptions of homogeneity of radionuclide deposition in tissues. The distribution of radiolabeled Microlite has been quantitated in mouse liver at the millimeter (multicellular) and the micrometer (cellular) levels. Measurements of radioactivity in 1-mm3 tissue samples indicate homogeneous radionuclide distribution; those derived from autoradiographs of 0.5-micron tissue sections show that, relative to other cells, the colloid was concentrated 200- to 1000-fold in liver macrophages. The dosimetric implications of such inhomogeneous radionuclide distribution in human liver, where similar radionuclide distribution is expected, are discussed on the basis of a recently developed model for calculating the dose at the cellular level, and the estimates are compared to conventional internal dosimetry predictions. It is demonstrated that during routine diagnostic examinations with 99mTc-Microlite, conventional dosimetry underestimates the dose to labeled human liver cells by factors of 8-30.
Insights
Conventional internal dosimetry underestimates radiation dose to human liver cells by 8-30 fold. This study reveals significant radionuclide concentration in liver macrophages, challenging homogeneity assumptions for accurate internal dosimetry.
Area of Science:
- Nuclear medicine
- Medical physics
- Toxicology
Background:
- Internal dosimetry typically assumes uniform radionuclide distribution in tissues.
- This assumption may not accurately reflect the complex cellular distribution of radiopharmaceuticals.
- Accurate dosimetry is crucial for assessing radiation risks in diagnostic and therapeutic procedures.
Purpose of the Study:
- To experimentally examine the homogeneity assumption in internal dosimetry.
- To quantify the distribution of radiolabeled Microlite in mouse liver at cellular and multicellular levels.
- To assess the dosimetric implications of inhomogeneous radionuclide distribution in human liver.
Main Methods:
- Quantification of radiolabeled Microlite distribution in mouse liver tissue samples (1-mm3).
- Autoradiography of 0.5-micron tissue sections to analyze cellular-level distribution.
- Application of a cellular-level dosimetry model to estimate radiation dose to human liver cells.
Main Results:
- Millimeter-scale samples suggested homogeneous radionuclide distribution.
- Micrometer-scale analysis revealed 200- to 1000-fold higher concentration of radiolabeled Microlite in liver macrophages compared to other cells.
- Conventional dosimetry underestimated the dose to human liver cells by factors of 8-30 during diagnostic procedures using 99mTc-Microlite.
Conclusions:
- The homogeneity assumption in conventional internal dosimetry is flawed.
- Inhomogeneous radionuclide distribution, particularly in macrophages, significantly impacts radiation dose calculations.
- Current dosimetry methods may underestimate radiation exposure to specific cell populations in the liver, necessitating revised models for accurate risk assessment.